# Research Design Template: Epidemiological Study Planning

**Instructions**: Use this template to plan your epidemiological study. Fill in each section with detailed information. This template ensures comprehensive study planning and helps identify potential issues early.

---

## 1. Research Question & Objectives

### Primary Research Question
**State your main question in PICO format:**
- **P**opulation:
- **I**ntervention/Exposure:
- **C**omparison:
- **O**utcome:

### Secondary Objectives
1.
2.
3.

### Hypotheses
- **Null hypothesis (H₀)**:
- **Alternative hypothesis (H₁)**:

---

## 2. Study Design Selection

### Chosen Study Design
- [ ] Cohort study (prospective/retrospective)
- [ ] Case-control study
- [ ] Cross-sectional study
- [ ] Randomized controlled trial
- [ ] Other: ________________

### Rationale for Design Choice
**Why is this design appropriate for your research question?**
- Frequency of exposure: ________ (common/rare)
- Frequency of outcome: ________ (common/rare)
- Resources available: ________
- Ethical considerations: ________
- Feasibility: ________

### Design Strengths
1.
2.
3.

### Design Limitations
1.
2.
3.

---

## 3. Study Population & Sampling

### Target Population
**Who is your study intended to represent?**
- Definition:
- Inclusion criteria:
- Exclusion criteria:

### Source Population
**From where will participants be drawn?**
- Geographic area:
- Time period:
- Data sources:

### Sampling Method
- [ ] Probability sampling
  - [ ] Simple random
  - [ ] Stratified
  - [ ] Cluster
  - [ ] Systematic
- [ ] Non-probability sampling
  - [ ] Convenience
  - [ ] Purposive
  - [ ] Snowball

### Sample Size Calculation
**Justification:**
- Expected effect size: ________
- Power: ________ (usually 80%)
- Alpha: ________ (usually 0.05)
- Anticipated drop-out rate: ________%

**Formula used:**
```
n = (Zα + Zβ)² × (p1(1-p1) + p2(1-p2)) / (p1-p2)²
```

**Calculated sample size:**
- Total sample: ________
- Per group: ________

---

## 4. Exposure & Outcome Definition

### Exposure Definition
**How will exposure be defined and measured?**
- Definition:
- Measurement method:
- Categories/levels:
- Timing of assessment:
- Validation method:

### Outcome Definition
**How will outcome be defined and measured?**
- Definition:
- Measurement method:
- Timing of assessment:
- Blinding of assessors: Yes/No
- Validation method:

### Data Collection Tools
- Questionnaire/interview:
- Biological samples:
- Medical records:
- Administrative data:
- Other:

---

## 5. Bias & Confounding Control

### Potential Biases

#### Selection Bias
- **Sources identified:**
  1.
  2.
  3.
- **Prevention strategies:**
  1.
  2.
  3.

#### Information Bias
- **Sources identified:**
  1.
  2.
  3.
- **Prevention strategies:**
  1.
  2.
  3.

#### Confounding Bias
- **Potential confounders:**
  1.
  2.
  3.
  4.
  5.
- **Control methods:**
  - [ ] Randomization
  - [ ] Restriction
  - [ ] Matching
  - [ ] Stratification
  - [ ] Statistical adjustment
  - [ ] Propensity scores

### Effect Modification
**Variables that might modify the exposure-outcome relationship:**
1.
2.
3.

**How will you test for interaction?**

---

## 6. Data Analysis Plan

### Descriptive Analysis
- **Participant characteristics:**
- **Exposure distribution:**
- **Outcome distribution:**
- **Missing data patterns:**

### Primary Analysis
- **Measure of association:**
  - [ ] Relative Risk (RR)
  - [ ] Odds Ratio (OR)
  - [ ] Risk Difference (RD)
  - [ ] Other: ________
- **Statistical test:**
- **Software:** ________

### Secondary Analyses
1. **Subgroup analyses:**
2. **Sensitivity analyses:**
3. **Interaction testing:**

### Handling Missing Data
- **Strategy:**
  - [ ] Complete case analysis
  - [ ] Multiple imputation
  - [ ] Last observation carried forward
  - [ ] Other: ________

---

## 7. Validity Assessment

### Internal Validity
**Threats and mitigations:**
- Threat 1: ________________ → Mitigation: ________________
- Threat 2: ________________ → Mitigation: ________________
- Threat 3: ________________ → Mitigation: ________________

### External Validity
**Generalizability considerations:**
- Study population vs. target population:
- Setting (clinic/community/hospital):
- Time period applicability:
- Intervention deliverability:

### Construct Validity
**Measurement validity:**
- Exposure measurement validity:
- Outcome measurement validity:
- Potential misclassification:

---

## 8. Ethical Considerations

### Informed Consent
- **Process:**
- **Information provided:**
- **Voluntariness:**
- **Documentation:**

### Risk Assessment
- **Physical risks:**
- **Psychological risks:**
- **Privacy/confidentiality risks:**
- **Mitigation strategies:**

### Vulnerable Populations
- **Groups involved:**
- **Additional protections:**
- **Ethical approvals needed:**

### Data Management
- **Storage:**
- **Security:**
- **Access controls:**
- **Retention period:**

---

## 9. Timeline & Resources

### Study Timeline
- **Planning phase:** ________ months
- **Recruitment:** ________ months
- **Data collection:** ________ months
- **Analysis:** ________ months
- **Reporting:** ________ months
- **Total duration:** ________ months

### Budget Estimate
- **Personnel:** ________
- **Equipment:** ________
- **Travel:** ________
- **Data management:** ________
- **Other:** ________
- **Total:** ________

### Team Members & Roles
1. **Principal Investigator:** ________________
2. **Data Manager:** ________________
3. **Field Coordinator:** ________________
4. **Statistician:** ________________
5. **Other:** ________________

---

## 10. Quality Assurance & Monitoring

### Data Quality Control
- **Training procedures:**
- **Monitoring visits:**
- **Data validation:**
- **Audit procedures:**

### Protocol Deviations
- **Reporting mechanism:**
- **Amendment procedures:**
- **Documentation:**

### Safety Monitoring
- **Adverse event reporting:**
- **Stopping rules:**
- **Independent monitoring:**

---

## 11. Dissemination Plan

### Publications
- **Primary manuscript:**
- **Secondary analyses:**
- **Protocol paper:**
- **Target journals:**

### Presentations
- **Conferences:**
- **Stakeholder meetings:**
- **Public engagement:**

### Data Sharing
- **Repository:**
- **Access conditions:**
- **Timeline:**

---

## 12. Contingency Planning

### Potential Challenges
1. **Low recruitment:** ________________
2. **High drop-out:** ________________
3. **Measurement issues:** ________________
4. **Resource constraints:** ________________

### Alternative Strategies
- **Backup recruitment sites:**
- **Alternative measurement methods:**
- **Reduced sample size options:**
- **Extended timeline options:**

---

## 13. References & Supporting Documents

### Key Literature
1.
2.
3.

### Similar Studies
1.
2.
3.

### Methodological References
1.
2.
3.

### Appendices
- **Detailed protocol:**
- **Data collection forms:**
- **Statistical analysis plan:**
- **Informed consent form:**
- **Ethical approval documents:**

---

## Checklist: Template Completion

- [ ] Research question clearly stated
- [ ] Study design justified
- [ ] Population and sampling defined
- [ ] Exposure/outcome clearly defined
- [ ] Bias/confounding addressed
- [ ] Analysis plan detailed
- [ ] Ethics considered
- [ ] Resources identified
- [ ] Quality assurance planned
- [ ] Dissemination planned
- [ ] Contingencies identified

**Date completed:** ________________
**Reviewed by:** ________________
**Approved by:** ________________

---

## Study Design Decision Tree (Reference)

```
Research Question
        ↓
Can experiment ethically?
        ↓
Yes → Experimental (RCT)
        ↓
No → Observational
        ↓
Outcome frequency?
        ↓
Rare → Case-control
        ↓
Common → Exposure frequency?
        ↓
Rare → Cohort
        ↓
Common → Cross-sectional
```

## Common Pitfalls to Avoid

1. **Unclear research question** → Refine until specific
2. **Inappropriate design** → Match design to question
3. **Inadequate sample size** → Calculate properly
4. **Poor measurement** → Validate instruments
5. **Ignoring bias/confounding** → Plan control strategies
6. **Weak analysis plan** → Consult statistician early
7. **Ethical shortcuts** → Follow guidelines strictly
8. **Resource mismatch** → Be realistic about constraints

This template ensures comprehensive study planning and helps identify potential issues before study initiation. Regular review and updates are recommended throughout the study lifecycle.
